Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis

Documenti analoghi

• Real‐world evidence for comprehensive evaluation of guselkumab in the treatment of psoriasis
  di: Diamant Thaçi
  Pubblicazione: (2025)
• Belgian recommendations for managing psoriasis in a changing treatment landscape
  di: R. Speeckaert, et al.
  Pubblicazione: (2024)
• Eczematous reaction to guselkumab successfully treated with upadacitinib
  di: Hector Moreno‐Davila, et al.
  Pubblicazione: (2025)
• Optical coherence tomography‐based imaging biomarkers for disease activity monitoring in plaque psoriasis
  di: L. Ha‐Wissel, et al.
  Pubblicazione: (2024)
• Nail clipping may not be sufficient to corroborate the diagnosis of psoriasis
  di: L. Bertanha, et al.
  Pubblicazione: (2024)